The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.

Jabbour E, Short NJ, Jain N, Haddad FG, Welch MA, Ravandi F, Kantarjian H

Open source

DOI
10.1186/s13045-023-01409-5
Published
2023 Mar 16
Container
Journal of hematology & oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13045-023-01409-5,
  title = {The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.},
  author = {Jabbour E and Short NJ and Jain N and Haddad FG and Welch MA and Ravandi F and Kantarjian H},
  year = {2023},
  journal = {Journal of hematology \& oncology},
  doi = {10.1186/s13045-023-01409-5},
  url = {https://doi.org/10.1186/s13045-023-01409-5}
}

RIS

TY  - JOUR
TI  - The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.
AU  - Jabbour E
AU  - Short NJ
AU  - Jain N
AU  - Haddad FG
AU  - Welch MA
AU  - Ravandi F
AU  - Kantarjian H
PY  - 2023
JO  - Journal of hematology & oncology
DO  - 10.1186/s13045-023-01409-5
UR  - https://doi.org/10.1186/s13045-023-01409-5
ER  - 

APA

E, J., NJ, S., N, J., FG, H., MA, W., F, R., & H, K. (2023). The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.. Journal of hematology & oncology. https://doi.org/10.1186/s13045-023-01409-5

Source records